Since several lines of evidence have implied the important role of activation of NOTCH1 signaling pathway in tumorigenesis, cell proliferation, cancer stem cell formation and maintenance, and progression in OSCC [36–38], we then determined whether GC-7 treatment affects the expression of NOTCH1 and HES1, a downstream transcription factor of NOTCH signaling. The gene discussed is HES1; the disease is cancer.